Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07365709

Liver Cirrhosis Complicated by Clinically Significant Portal Hypertension

Liver Cirrhosis Complicated by Clinically Significant Portal Hypertension: the Role of Contrast-enhanced Ultrasound and Splenic Elastography for Non-invasive Assessment

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
107 (estimated)
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Portal hypertension is a major complication of cirrhosis. HVPG is the diagnostic gold standard but is invasive. Non-invasive tools such as spleen stiffness measurement (SSM) and CEUS show promise for assessing CSPH, though they have not yet been compared directly. A multimodal ultrasound approach may provide a reliable alternative to HVPG.

Conditions

Interventions

TypeNameDescription
DRUGSonoVuemicrobubbles infusion and ultrasound

Timeline

Start date
2026-02-01
Primary completion
2026-07-31
Completion
2026-12-31
First posted
2026-01-26
Last updated
2026-01-26

Source: ClinicalTrials.gov record NCT07365709. Inclusion in this directory is not an endorsement.